I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 136 filers reported holding I MAB in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,122 | -55.9% | 850,000 | 0.0% | 0.05% | -39.2% |
| Q2 2023 | $2,542 | -13.6% | 850,000 | 0.0% | 0.08% | -54.9% |
| Q1 2023 | $2,941 | -17.2% | 850,000 | 0.0% | 0.18% | -11.6% |
| Q4 2022 | $3,553 | -99.9% | 850,000 | 0.0% | 0.20% | +36.6% |
| Q3 2022 | $3,409,000 | -64.5% | 850,000 | 0.0% | 0.14% | -71.7% |
| Q2 2022 | $9,605,000 | -30.4% | 850,000 | 0.0% | 0.51% | -11.2% |
| Q1 2022 | $13,804,000 | -65.7% | 850,000 | 0.0% | 0.58% | -47.1% |
| Q4 2021 | $40,282,000 | -32.6% | 850,000 | +3.0% | 1.09% | -18.3% |
| Q3 2021 | $59,804,000 | -5.0% | 825,000 | +10.0% | 1.34% | +4.7% |
| Q2 2021 | $62,963,000 | +73.2% | 750,000 | 0.0% | 1.28% | +99.1% |
| Q1 2021 | $36,353,000 | +6.3% | 750,000 | +3.4% | 0.64% | -12.5% |
| Q4 2020 | $34,184,000 | +0.3% | 725,000 | 0.0% | 0.73% | -11.4% |
| Q3 2020 | $34,097,000 | +251.6% | 725,000 | +123.8% | 0.83% | +205.5% |
| Q2 2020 | $9,697,000 | +113.1% | 324,000 | -7.4% | 0.27% | +41.1% |
| Q1 2020 | $4,550,000 | – | 350,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |